Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology, and risk factors. World J Oncol. 2019;10(1):10–27.

Article  PubMed  PubMed Central  Google Scholar 

Berry W, Lundy J, Croagh D, et al. Reviewing the utility of EUS FNA to advance precision medicine in pancreatic cancer. Cancers (Basel). 2018;10(1):35.

Article  PubMed  Google Scholar 

Saqib M, Maruf M, Bashir S, et al. EUS-FNA, ancillary studies, and their clinical utility in patients with mediastinal, pancreatic, and other abdominal lesions. Diagn Cytopathol. 2020;48(11):1058–66.

Article  PubMed  Google Scholar 

Park JK, Lee KH. Present and future of endoscopic ultrasound-guided tissue acquisition in solid pancreatic tumors. Clin Endosc. 2019;52(4):541–8.

Article  PubMed  PubMed Central  Google Scholar 

de Jong K, Verlaan T, Dijkgraaf MG, et al. Interobserver agreement for endosonography in the diagnosis of pancreatic cysts. Endoscopy. 2011;43(6):579–84.

Article  PubMed  Google Scholar 

Sweeney J, Rao R, Margolskee E, et al. Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma. J Am Soc Cytopathol. 2018;7(2):318–23.

Article  PubMed  Google Scholar 

Senoo J, Mikata R, Kishimoto T, et al. Immunohistochemical analysis of IMP3 and p53 expression in endoscopic ultrasound-guided fine needle aspiration and resected specimens of pancreatic diseases. Pancreatology. 2018;18(2):176–83.

Article  CAS  PubMed  Google Scholar 

Tadic M, Stoos-Veic T, Kujundzic M, et al. Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma. Eur J Gastroenterol Hepatol. 2020;32(3):496–500.

Article  CAS  PubMed  Google Scholar 

Ohuchida K, Mizumoto K, Egami T, et al. S100P is an early developmental marker of pancreatic carcinogenesis. Clin Cancer Res. 2006;12(19):5411–6.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Yang J, Li H, et al. Tumor markers CA19-9, CA242, and CEA in the diagnosis of pancreatic cancer: a meta-analysis. Int J Clin Exp Med. 2015;8(8):11683–91.

PubMed  PubMed Central  Google Scholar 

Hu H, Zhang Q, Huang C, et al. Diagnostic value of S100P for pancreatic cancer: a meta-analysis. Tumour Biol. 2014;35(10):9479–85.

Article  CAS  PubMed  Google Scholar 

Chiba M, Imazu H, Kato M, et al. Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma. Oncol Rep. 2017;37(4):1943–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burdelski C, Jakani-Karimi N, Jacobsen F, et al. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: a tissue microarray study on 8,877 human cancers and normal tissues. Oncol Rep. 2018;39(1):3–12.

CAS  PubMed  Google Scholar 

Wang JD, Jin K, Chen XY, et al. Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis. Oncotarget. 2017;8(13):16704–11.

Article  PubMed  Google Scholar 

Matsuda Y, Esaka S, Suzuki A, et al. Abnormal immunolabelling of SMAD4 in cell block specimens to distinguish malignant and benign pancreatic cells. Cytopathology. 2019;30(2):201–8.

Article  PubMed  Google Scholar 

Wang Z, Tian YP. Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma. Mol Clin Oncol. 2014;2(3):265–8.

Article  CAS  PubMed  Google Scholar 

Boeck S, Wittwer C, Heinemann V, et al. Cytokeratin 19-fragments (CYFRA 21–1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer. Br J Cancer. 2013;108(9):1684–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imaoka H, Mizuno N, Hara K, et al. Prognostic impact of carcinoembryonic antigen (CEA) on patients with metastatic pancreatic cancer: a retrospective cohort study. Pancreatology. 2016;16(6):859–64.

Article  CAS  PubMed  Google Scholar 

Kato H, Kishiwada M, Hayasaki A, et al. Role of serum carcinoma embryonic antigen (CEA) level in localized pancreatic adenocarcinoma: CEA level before operation is a significant prognostic indicator in patients with locally advanced pancreatic cancer treated with neoadjuvant therapy followed by surgical resection: a retrospective analysis. Ann Surg. 2022;275(2):e698–707.

Article  PubMed  Google Scholar 

Maire F, Voitot H, Aubert A, et al. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Am J Gastroenterol. 2008;103(11):2871–7.

Article  PubMed  Google Scholar 

Parkkila S, Pan PW, Ward A, et al. The calcium-binding protein S100P in normal and malignant human tissues. BMC Clin Pathol. 2008;8:2.

Article  PubMed  PubMed Central  Google Scholar 

Nakayama H, Ohuchida K, Yonenaga A, et al. S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer. Int J Oncol. 2019;55(1):211–22.

CAS  PubMed  Google Scholar 

Tascilar M, Skinner HG, Rosty C, et al. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2001;7(11):4115–21.

CAS  PubMed  Google Scholar 

Garg SK, Chari ST. Early detection of pancreatic cancer. Curr Opin Gastroenterol. 2020;36(4):456–61.

Article  PubMed  Google Scholar